Study on International Regulatory Harmonization Published in Harvard Business Review

Call for a Human Moonshot at Forbes China Healthcare Summit

Greg Simon, the Founding Executive Director of the White House Cancer Moonshot called for a “Human Moonshot” to promote international cancer clinical trials cooperation and bring breakthroughs to people all over the world

FDA grants double accelerated approval of trastuzmab deruxtecan (Enhertu)

FDA granted accelerated approval of trastuzumab deruxtecan (Enhertu) for patients with HER2-low breast cancer and HER2-mutant lung cancer based on international trials.

A Post-Pandemic Era White Paper Published in Nature Medicine

European Union Clinical Trials Regulation Came into Effect

European Union Clinical Trials Regulation came into effect to harmonize submissions in a single application for all member states.

European Union Clinical Trials Regulation Came into Effect

Biden reignites the Cancer Moonshot, setting ambitious goals: to reduce the death rate from cancer by at least 50 percent over the next 25 years

International Cancer Coalition Launch

In 2021, the International Cancer Coalition officially launched at the Bloomberg New Economy Forum in Singapore.

Forbes China Healthcare Summit opens the door to “Ping-Pong Diplomacy of the 21st Century”

The 2021 Forbes China Healthcare Summit was held to discuss the theme of “Advance the Global Fight Against Cancer and Achieve a Moonshot in the Post-Pandemic Era.”

FDA granted accelerated approval to sotorasib (Lumakras)

A pandemic-era CodeBreaK100 international trial led to FDA accelerated approval of sotorasib (Lumakras), the first targeted drug against KRAS, the commonest oncogene driver in human cancers which was previously thought to be uncurable.

Forbes China Healthcare Summit launched

Forbes China Healthcare Summit launched, bringing together leading academic, industry, and government stakeholders in the U.S. and China to collaborate on international clinical trials in the COVID-19 pandemic era.